Lista de obras - Anna Baran - Dominio Público Uruguay

Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin

scientific article published on 08 July 2019

Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).

artículo científico publicado en 2016

Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).

artículo científico publicado en 2017

Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels

artículo científico publicado en 2016

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.

artículo científico publicado en 2014

Effect of psoriasis activity on serum adiponectin and leptin levels.

artículo científico publicado en 2015

Fatty Acid-Binding Proteins in Psoriasis—A Review

artículo científico publicado en 2022

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients

scientific article published on 17 December 2016

Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis

artículo científico publicado en 2017

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.

artículo científico publicado en 2019

Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

artículo científico publicado en 2020

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome? ⬇️

artículo científico publicado en 2020

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis

artículo científico publicado en 2016

Serum YKL-40 as a potential biomarker of inflammation in psoriasis

artículo científico publicado en 2017

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.

artículo científico publicado en 2014

Serum fatty acid profile in psoriasis and its comorbidity

artículo científico publicado en 2017

Serum irisin levels in patients with psoriasis.

artículo científico publicado en 2016

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients

scientific article published on 13 December 2019

The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.

artículo científico publicado en 2015

Upregulation of the sFas/sFasL system in psoriatic patients

artículo científico publicado en 2014

Lista de obras de Anna Baran

Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin

Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).

Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).

Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.

Effect of psoriasis activity on serum adiponectin and leptin levels.

Fatty Acid-Binding Proteins in Psoriasis—A Review

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients

Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.

Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome? ⬇️

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis

Serum YKL-40 as a potential biomarker of inflammation in psoriasis

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.

Serum fatty acid profile in psoriasis and its comorbidity

Serum irisin levels in patients with psoriasis.

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients

The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.

Upregulation of the sFas/sFasL system in psoriatic patients